Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD

BACKGROUND: The Clopidogrel and Acetylsalicylic Acid in Bypass Surgery for Peripheral Arterial Disease (CASPAR) trial is the only large, double‐blind, placebo‐controlled trial of dual antiplatelet therapy (DAPT) versus aspirin in patients with peripheral artery disease (PAD) after lower extremity re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonaca, Marc P., Szarek, Michael, Debus, E. Sebastian, Nehler, Mark R., Patel, Manesh R., Anand, Sonia S., Muehlhofer, Eva, Berkowitz, Scott D., Haskell, Lloyd P., Bauersachs, Rupert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748742/
https://www.ncbi.nlm.nih.gov/pubmed/36251249
http://dx.doi.org/10.1002/clc.23926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748742/
https://www.ncbi.nlm.nih.gov/pubmed/36251249
http://dx.doi.org/10.1002/clc.23926

Ejemplares similares